BRIEF-Bristol-Myers Squibb receives positive CHMP opinion recommending opdivo
March 24, 2017 at 09:17 AM EDT
* Bristol-Myers Squibb receives positive chmp opinion recommending opdivo (nivolumab) for the treatment of squamous cell cancer of the head and neck in adults progressing on or after platinum-based therapy
